Skip to content
MatchScript
Menu

Head-to-head · The Match Score

Hims & Hers vs Henry Meds

Both scored on the same six-factor Match Score. Hims & Hers wins this matchup with a 83 to 82 edge — a photo finish.

Higher Match Score

Hims & Hers

#17 · Grade B

People who want a familiar, app-driven consumer brand and fast nationwide onboarding.

Visit Hims & Hers
VS

Henry Meds

#19 · Grade B−

People who want a simple, well-known flat-fee compounded program.

Visit Henry Meds

Factor by factor

The six sub-scores behind each Match Score. The quiz reweights these to your priorities — one provider can pull ahead for you on the factors you care about.

Budget Fit
80
72
Speed to Start
92
84
Formulary Match
76
80
Support Level
86
84
Flexibility
84
86
Transparency
82
86

Price, coverage & formulary

DetailHims & HersHenry Meds
Semaglutide$199/mo$249/mo
TirzepatideNot disclosed$349/mo
CoverageAll 50 statesMulti-state
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjectable onlyInjectable only
Match Score83 · B82 · B−
Winner: Hims & Hers

Hims & Hers edges out Henry Meds, 83 to 82 on the default Match Score. Mass-market, app-first weight program with nationwide reach and consumer-grade polish.

Henry Meds is still a fair pick if its strengths line up with yours — best for: People who want a simple, well-known flat-fee compounded program.

Worth a look either way: our overall #1 pick is CoreAge Rx (Match Score 91) — nationwide access, both molecules at one flat price, easy to cancel. Or take the 6-question quiz to see your personalized match.

Assume any provider we list may compensate us, at no cost to you. It never changes the Match Score.

Full Hims & Hers reviewFull Henry Meds review

More head-to-heads

Or browse alternatives to Hims & Hers and all comparisons.

Pricing, states and verification reflect each provider's public disclosures at last review; the Match Score and its sub-scores are our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.